Title: Anti-cancer nanomedicine in humans: A review and future directions

This presentation will cover a close to 30 year journey researching and commercializing nanotechnology for improving disease prevention, diagnosis, and treatment (including cancer) which has led to numerous products including nano spinal implants now in over 30,000 patients to da [....] » Read More

Title: Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: an option for clinical oncologists, caregiv-ers and consumers to secure the human biosafety

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based medicine and thus genomics biomarkers promises to provide molecular tests that will pe [....] » Read More

Title: Prospecting fluorine-doped graphene in photodynamic therapy

Halogen-decorated graphene quantum dots (X@GQDs) will be herein explored as a material platform for application in photodynamic therapy (PDT). GQDs have been extensively studied in biomedical areas such as bioimaging, bio-sensing and photothermal therapy due to their superior opt [....] » Read More

Title: Precision oncology strategy for cancer care team: Developing targeted cancer therapy & advancing personalized cancer

A comprehensive molecular tumor analysis integrating a combination of NGS methods including whole-exome (WES), whole-genome (WGS) and transcriptome sequencing (RNAseq) offers the best chance for personalizing cancer care, enlarging the scope of therapy choices and offering potent [....] » Read More

Title: How to chose right Clinical Research Organization (CRO) partner when developing new cancer drug while meeting challenges of current critical trends in oncology drug development?

During the last decade there have been major breakthroughs in cancer treatment options driven by immunotherapy and most recently cell and gene products. With increased number of new cancer drug candidates entering clinical development there is elevated need for identification of [....] » Read More